A 35-year-old woman presents with a 1.5 cm firm, mobile breast mass in the left breast that has been stable for 2 years. Ultrasound shows a well-defined, hypoechoic oval lesion with sharp margins and posterior acoustic enhancement, consistent with fibroadenoma. The patient is asymptomatic and requests confirmation before deciding on management. Which investigation would provide the most specific tissue diagnosis with the least morbidity?

Explanation

## Most Specific Tissue Diagnosis with Least Morbidity **Key Point:** Fine-needle aspiration cytology (FNAC) under ultrasound guidance is the minimally invasive gold standard for tissue diagnosis of fibroadenoma when imaging features are characteristic. ### Diagnostic Hierarchy for Benign Breast Lesions ```mermaid flowchart TD A[Palpable breast mass]:::outcome --> B{Imaging findings suggestive of benign lesion?}:::decision B -->|Yes, classic features| C[Ultrasound-guided FNAC]:::action B -->|Indeterminate| D[Core needle or vacuum biopsy]:::action B -->|Suspicious for malignancy| E[Excision biopsy]:::action C --> F[Fibroadenoma confirmed]:::outcome D --> G[Definitive tissue diagnosis]:::outcome E --> H[Histopathology + treatment]:::outcome ``` ### Comparison of Diagnostic Modalities | Investigation | Sensitivity | Specificity | Invasiveness | Radiation | Best Use | |---|---|---|---|---|---| | **FNAC** | 85–95% | 95–98% | Minimal | No | Benign lesions with classic features | | Vacuum-assisted biopsy | 98–99% | 99–100% | Moderate | No | Indeterminate or high-risk lesions | | Excision biopsy | 100% | 100% | High | No | Therapeutic + diagnostic | | MRI | 90–95% | 70–80% | None | No | Problem-solving, multifocal disease | **High-Yield:** FNAC provides **cytologic confirmation** (not histologic) but is sufficient for fibroadenoma diagnosis when imaging is classic; it avoids unnecessary tissue removal in a benign lesion. ### Why FNAC Is Preferred Here 1. **Characteristic ultrasound features** already present (well-defined, hypoechoic, posterior acoustic enhancement) 2. **Minimal tissue trauma** — no surgical scar, minimal pain 3. **Cost-effective** — important in Indian healthcare setting 4. **Rapid results** — cytology turnaround typically 2–3 days 5. **Adequate for benign diagnosis** — fibroadenoma cytology is distinctive (epithelial and myoepithelial cells in clusters) **Clinical Pearl:** The "triple assessment" (clinical examination + imaging + tissue diagnosis) has >99% diagnostic accuracy for benign vs. malignant lesions. FNAC completes this assessment without morbidity. ### Why Not Other Options? - **Mammography with magnification:** Imaging modality, not tissue diagnosis; adds no diagnostic value when ultrasound is already conclusive - **Vacuum-assisted biopsy:** Provides histology (more tissue) but is over-treatment for a lesion with classic benign imaging; reserved for indeterminate or high-risk lesions - **MRI breast:** Problem-solving tool for multifocal disease or silicone implant evaluation; not indicated for a single well-characterized benign lesion **Mnemonic:** **FNAC for Fibroadenoma** — **F**ine-needle, **N**o-scar, **A**ccurate, **C**ost-effective.